Table 2.

Demographic features of patients with progressive supranuclear palsy and healthy control subjects

	Patients	Control subjects	p Value
n	16	14
Age at death, years	72.5 (6.92)a	75.7 (10.07)	0.34
Male sex, n (%)	9 (56)	9 (64)	0.8
Disease duration, years	8.2 (2.26)a	–	–
Postmortem delay, h, mean (SD)	6.29 (1.21)	7.53 (1.31)	0.01

^aThree cases that underwent euthanasia were not included